Switzerland / Tillotts CEO Talks SME M&A Principles
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the…
Patrick Burton |
Editor
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
Articles: Patrick Burton
Mexico / Bayer Targets Cancer; Novartis Gets Aggressive; J&J Vaccines Arrive; Doctors Denied Jabs
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion…
MEA / Georg Schroeckenfuchs of Novartis: ‘Shooting for the Moon’ in Saudi
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA)…
Hong Kong / HKEX’s Aim to Become World’s #1 Biotech Listing Hub & Challenges for New CEO
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs…
Aducanumab Approval / Opening the Floodgates for a New Era of Alzheimer’s Treatment?
With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval…
Singapore / A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy,…
Switzerland / Upcoming Cost Containment Packages: Industry Key Concerns
While once considered the land of milk and honey within Europe in terms of market access and reimbursement for…
France / Germany Production Alliance Falters; Sanofi Vaccine Enters Phase III Trials; Valneva Still in the Vaccine Race
The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical…
China / Roche Hoping to Spearhead ‘Created in China’ Push with New Innovation Accelerator
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai, a USD 31.1 million investment…
Switzerland / What Novartis & Roche's Domestic Market Means to Them
The Novartis and Roche names are synonymous with Swiss pharmaceutical innovation. But for these two Basel-based…
China / BioNTech-Fosun JV; Patent Law Revamp; Hong Kong as a Biotech Listing Hub
The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up…
Germany / Merck KGaA Expecting More COVID-Related Deals; Digital Health Woes; CureVac Vaccine Potential vs Variants
The latest news from German pharma, including a new US leadership team and more COVID-related investment at Merck…